-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-325 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-325 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-325 in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-325 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-325 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-325 in Triple-Negative Breast Cancer (TNBC) Drug Details: BNT-325 (DB-1305)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1311 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1311 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1311 in Solid Tumor Drug Details: DB-1311 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DB-1311 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1311 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1311 in Non-Small Cell Lung Cancer Drug Details: DB-1311 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1303 in Vaginal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1303 in Vaginal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1303 in Vaginal Cancer Drug Details: DB-1303 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1303 in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1303 in Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1303 in Adenocarcinoma Drug Details: DB-1303 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1303 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1303 in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1303 in Metastatic Breast Cancer Drug Details: DB-1303 is under...
-
Thematic Analysis
NewDigital Twins – Thematic Intelligence
Digital Twins Thematic Report Overview Digital twins are digital representations of physical assets, systems, people, or processes. They help in detecting, preventing, predicting, and optimizing the physical environment using artificial intelligence (AI), real-time analytics, visualization, and simulation tools. Digital twins can provide short and long-term efficiency and productivity gains by dynamically integrating data and information about an asset, part, process, or system’s lifecycle. They are a data resource that can improve asset design, understand an existing asset’s condition, verify the...
-
Analyst Opinions
Immersive Enterprise – Sector Impact of Alternative Reality Technologies
Immersive Enterprise – Sector Impact of Alternative Reality Technologies Report Overview The immersive platform landscape is being shaped by a host of convergent trends, such as advanced hardware, 5G roll-out, cloud computing, miniaturization, and collaborative features among others. This report serves as an invaluable resource for gaining insights into how the adoption of immersive platforms not only enhances user experiences but also cultivates customer-centric strategies. In addition, the report highlights advantages, such as fostering greater engagement, accelerating training and learning,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1310 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1310 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1310 in Solid Tumor Drug Details: The therapeutic candidates are under...